Displaying 97 - 108 of 160
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
General Hepatology
5

Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
General Hepatology
4

Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022

View
Displaying 97 - 108 of 160